Aperio Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
Aperio Group's RGEN Position: Q4 2020 in Review
Aperio Group increased its Repligen (RGEN) stake by 20% in Q4 2020, buying an estimated $2.13M and bringing the position to 70,477 shares worth $13.5M. The position accounts for 0.04% of the portfolio, ranked #450.
Aperio Group first reported a position in RGEN in Q2 2015 and has held it in 20 quarters since. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.
- Aperio Group held 70,477 shares of Repligen worth $13.5M as of Q4 2020.
- Aperio Group bought 11,715 Repligen shares in Q4 2020, an estimated $2.13M.
- Repligen made up 0.04% of Aperio Group's portfolio in Q4 2020, its #450 holding.
- Aperio Group first reported a position in Repligen in Q2 2015 and has held it in 20 quarters since.
- 449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.